Companies /Healthcare

ARS Pharmaceuticals Inc

NASDAQ: SPRY Biotechnology
$6.03
â–² $0.00 (+0.00%) today
Markets closed · 7:36am ET
Today · % change

Fundamentals

Market Cap
$599.7M
Profit Margin
-184.2%
Revenue (TTM)
$116.9M
EPS (TTM)
$-2.18
52-Week Range
$5 – $13
Street Target
$23.25

About ARS Pharmaceuticals

ARS Pharmaceuticals Inc is a biopharmaceutical firm based in San Diego, California, focused on innovating allergy care. Founded in 2015, it's pioneering 'neffy,' a needle-free, intranasal epinephrine spray designed to offer a quick, easy-to-use emergency treatment for severe allergic reactions, including anaphylaxis. This breakthrough aims to empower patients and caregivers by providing a more accessible alternative to traditional methods.

SPRY Coverage

10:13am ET
Investing

5 Stocks Under $10 Growing 50% Or More

Are you looking for low-cost stocks to add to your portfolio? Doing so can be a challenge. After all, stocks that trade with low share prices are often risky investment opportunities. That’s…

Joshua Rodriguez